The Board of Directors of Hyundai Pharmaceutical Co., Ltd. has authorized a buyback plan on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,735 KRW | +0.13% | -1.19% | -9.12% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-9.12% | 75.72M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.